病毒学和临床反应的动力学参数的布莱维尔提德治疗D型肝炎:现实世界的数据

Alexander Killer1, Smaranda Gliga1, Carolin Lohr1

  • 1Department for Gastroenterology, Hepatology and Infectious Diseases, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.

Gastro hep advances
|August 12, 2024
PubMed
概括

针对乙型肝炎病毒 (HDV) 感染的布莱维尔提德治疗显示出肝脏的快速改善,ALT正常化之前的病毒反应. 延迟反应的预测因素包括严重的肝炎,低的BMI和高的α-fetoprotein.